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This study was conducted to detect the prevalence of Metallo-Beta-Lactamases (MBLs) and Extended-
Spectrum Beta-Lactamases (ESBLs) in bacterial isolates from clinical and community settings of two 
communities in Delta State, Nigeria. Eighty four isolates obtained from blood, urine, wound and stool of 
patients and community subjects were analyzed and identified by standard microbiological methods. 
Carbapenemase detection was carried out using modified Hodge test. EDTA-disc synergy test was used to 
detect MBLs production in 26.2% of the isolates. ESBLs production determined by double disc synergy test 
(DDST) was detected in 36.7% isolates of Escherichia coli, 37.5% of Pseudomonas aeruginosa and 75% 
of Klebsiella pneumoniae. Co-production of MBL and ESBL was observed in 31.8% of the isolates. The 
study observed 2 major troubling findings. The first is the prevalence and co-production of MBLs and ESBLs 
both in hospitalized patients and in isolates of healthy community children. Second, antibiotic resistant 
bacteria may be able to persist in the community free from the high selective pressure pervading in clinical 
settings. There is therefore the need for increased surveillance. 
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INTRODUCTION 
The emergence of multi-drug resistant pathogenic 
bacteria generally considered a major clinical 
crisis has steadily increased over the last two 
decades (Gniadedkowski, 2001). Beta-lactam 
antibiotics are among the most employed drugs 
for the treatment of serious bacterial infections. 
The most active of this group is the 
carbapenems. Gram negative bacteria have 
developed a variety of resistance mechanisms to 
the beta-lactams including hydrolysis of beta-
lactam ring by beta-lactamases, alteration in the 
penicillin-binding proteins, decrease in outer 
membrane permeability and expression of efflux 
pumps. The beta-lactamase enzymes including 
the extended spectrum beta-lactamases (ESBLs) 
and the carbapenemases are usually plasmid 
mediated and have been mainly reported in 
Enterobacteriaceae such as Escherichia coli, 
Klebsiella pneumonia and in Pseudomonas 
aeruginosa (Paterson and Bonomo, 2005). The 
ESBL enzymes confer resistance to the 
cephalosporins and monobactams but are 
inhibited by β-lactam inhibitors (Paterson and 
Bonomo, 2005). The carbapenems are reliably 
active against bacteria harbouring ESBLs, as 
such carbapenems are often considered as the 
treatment option of last resort against infections 
caused by multidrug-resistant 
Enterobacteriaceae. 
 
The production of metallo-beta-lactamases is a 
major problem in the therapy of clinically ill 
patients. Acquired MBL genes are located on the 
integron which enable wide spread dissemination 
(Walsh et al., 2005). MBL and ESBL-producing 
Enterobacteriaceae are prevalent in the hospital 
setting (Brolund, 2014; Dortet et al., 2014). 
However, there have been reports of their 
emergence and spread in the community as well 
(Smith et al., 2004; Pitout et al., 2005). Their 
presence in the community greatly increases the 
risk of other individuals becoming carriers via 
human-to-human transmission (Levin, 2001). It is 
therefore important to monitor the prevalence of 
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organisms producing these enzymes in the 
community to prevent further spread.  
This study was thus designed to investigate the 
prevalence of organisms producing MBLs and 
ESBLs in hospitals and in some communities of 
Delta State, Nigeria. 
 
MATERIALS AND METHODS 
Ethical approval for the study was granted by the 
ethical committee of Baptist Medical Center, Eku 
and General Hospital Abraka, Delta State, while 
consent for participation was sought through the 
school authorities, parents and hospitalized 




Stool samples were collected from100 healthy 
children attending primary schools of in Abraka 
and Eku communities in Delta State. The stool 
samples were collected in dry sterile containers 
and transported immediately in ice packs to the 
laboratory for analysis. A total of 120 clinical 
specimens of wound, blood, and urine were 
obtained from hospitalized patients in General 
Hospital Abraka and Baptist Medical Center, Eku. 
Wounds were cleaned with normal saline solution 
prior to collection and sterile swab sticks were 
used to obtain wound samples. Midstream urine 
was collected from patients in sterile containers 
while blood samples were collected (with the help 
of trained health personnel) by venipuncture 
using 10 cm3 syringe after cleaning with an 
alcohol swab and finally dispensed into EDTA 
treated sample containers. 
 
Isolation and Identification of Esherichia coli, 
Pseudomonas aeruginosa and Klebsiella 
pnuemoniae 
Blood samples were inoculated into Brain Heart 
Infusion broth and were incubated overnight. 
Blind sub-culture was done onto fresh 5% sheep 
blood agar and MacConkey agar. A negative 
result was followed up by examining the broth 
daily and doing a final sub-culture at the end of 
the 7th day or at the appearance of turbidity. Urine 
samples were inoculated onto cystine lactose 
electrolyte deficient (CLED) agar and MacConkey 
agar. Wound swabs were inoculated onto 
MacConkey agar and Blood agar. Stool samples 
were inoculated onto MacConkey agar plates. 
The plates were incubated for 24 h at 37ºC under 
aerobic conditions. Colonies that appeared 
mucoid, lactose fermenting on MacConkey, gray 
or yellow on blood and CLED agar respectively 
were suggestive of E.coli and 
K.pnuemoniae.Also,mucoid and nonlactose 
fermenting colonies on MacConkey agar,gray on 
blood agar were suggestive of P. aeruginosa. 
These colonies were sub cultured onto nutrient 
agar plates and incubated for 24 h at 37ºC for the 
isolation of pure cultures. All isolates were further 
screened using conventional biochemical tests 
which include Triple sugar iron (TSI), IMViC, 
urease production, catalase, oxidase and motility 
(Table 1). Presumptive P. aeruginosa was also 
characterized on its ability to grow at 42ºC 
(Cheesbrough, 2006). 
 
Screening of Isolates for Carbapenemase 
Production 
Carbapenemase production was detected in each 
of the isolates using the Modified Hodge Test 
method (CLSI, 2009; Walsh et al., 2011). A 0.5 
McFarland dilution of Escherichia coli ATCC 
25922 in 5ml peptone water was prepared and 
diluted to 1:10 by adding 0.5ml of the 0.5 
McFarland E. coli ATCC 25922 to 4.5 ml peptone 
water. The 1:10 dilution of E. coli ATCC 25922 
was streaked using a sterile cotton swab on the 
surface of a Mueller-Hinton agar (MHA) plates. 
The plates were allowed to dry for about 10 
minutes and a 10 μg meropenem disk (Oxoid, 
England) was placed at the center of the plate 
and the test strain was streaked from the edge of 
the disk to the periphery of the plate in four 
different directions.  Thereafter, the plate was 
incubated overnight at 37°C. The presence of a 
cloverleaf-like indentation of E. coli ATCC 25922 
growing along the test isolate growth streak within 
the disc diffusion zone was considered as a 
positive result. 
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Metallo-β- Lactamases Detection 
EDTA-disc synergy test was used to detect MBL 
production in each of the isolates (CLSI, 2009; 
Walsh et al., 2011). Overnight suspensions of 
carbapenemase-producing isolates adjusted to a 
0.5 McFarland standard were streaked on the 
surface of MHA plates using sterile cotton swabs. 
The inoculated plates were allowed to sit for 
about 5 min, then two meropenem (MEM, 10μg) 
(Oxoid, England) discs, one impregnated with 
EDTA and the other without EDTA were placed 
on the surface of the MHA at a distance of about 
20 mm apart. The plates were incubated for 24 h 
at 37ºC. Zones of inhibition were recorded after 
24 h of incubation. Organisms that showed 
difference in diameter of zone of inhibition by 
≥7mm on the MEM containing EDTA and MEM 
alone were confirmed for the production of MBLs. 
 
ESBLs Detection Using Double Disc Synergy 
Test 
Overnight suspensions of the test organisms 
adjusted to a 0.5 McFarland standard were 
streaked on the surface of freshly prepared Muller 
Hinton agar plates using sterile cotton swabs. 
Amoxicillin-clavulanic acid discs (containing 
amoxicillin 20 µg/clavulanic acid 10 µg) were 
placed at the center of the inoculated plates. 
Ceftazidime (30 µg) and Cefotaxime (30 µg) 
discs (Oxoid, England) were each placed 20 mm 
centre apart from the Amoxicillin-clavulanic acid 
disc. The plates were then incubated for 24 h at 
37ºC. Organisms that showed an increase in zone 
of inhibition around any of the cephalosporins 
toward the amoxicillin-clavulanic acid disc by 




A total of 84 isolates obtained from stool (59), 
Urine (19), wound (3) and blood (3), were 
screened for metallo-beta-lactamase and 
extended spectrum beta-lactamase production. 
Forty (47.62%) were positive for carbapenemase 
production. Klebsiella pneumoniae (62.50%) had 
the highest prevalence, followed 
by Pseudomonas 
aeruginosa (50.00%). Escherichia coli had the 
lowest prevalence of 45.59% (Table 2).  
 




Escherichia coli Klebsiella pnuemoniae Pseudomonas 
aeruginosa 
Indole  + - - 
Methyl red + - - 
Voges-Proskauer - + - 
Citrate  - + + 
Urease - + - 
Catalase + + + 
Oxidase - - + 
Motility + - + 
Hydrogen sulfide - - - 
D-glucose (acid/gas) +/+ +/+ -/- 
Sucrose  + + - 
Lactose  + + - 
Key: + = test positive; - = test negative 
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Table 2: Occurrence of carbapenemase producer among bacterial isolates 
Isolates No of isolates screened No of isolates producing 
carbapenemase (%) 
Escherichia coli 68 31(45.59) 
Pseudomonas aeruginosa 8 4(50.00) 
Klebsiella pneumonia 8 5(62.50) 
Total 84 40(47.62) 
 
The number of MBL producers in this study was 
22 (26.19%). The highest prevalence of MBL 
production was observed in Klebsiella 
pneumoniae (37.50%), followed by E. 
coli (26.47%), and Pseudomonas 
aeruginosa (12.50%). Wound samples had the 
highest prevalence (66.67%) of MBL producers 
followed by urine (26.32%) and stool (25.42%) 
samples. No MBL producer was observed in 
blood samples. The highest ESBLs producer, 
was observed in urine samples (63.16%), 
followed by stool samples (33.90%) while both 
blood and wound samples had prevalence rates 
of 33.33%. (Table 3) 
 
Table 3: Distribution of ESBL producers according to sample 
 Urine Wound  Blood Stool  Total  
E. coli Number 
screened 
6 2 1 59 68 
ESBL 
producers 
4(66.67) 0 (0.00) 1(100.00) 20(33.90) 25(36.76) 
MBL 
producers 





6 1 1 0 8 
ESBL 
producers 
2(33.33) 1(100.00) 0(0.00) 0(0.00) 3(37.50) 
MBL 
producer 
1(50.00) 0(0.00) 0(0.00) 0(0.00) 1(12.50) 
Klebsiella pneumonia Number 
screened 
7 0 1 0 8 
ESBL 
producers 
6(85.71) 0.(0.00) 0(0.00) 0(0.00) 6(75.00) 
MBL 
producer 
3(42.85) 0(0.00) 0(0.00) 0(0.00) 3(37.50) 
TOTAL Number 
screened 
19 3 3 59 84 
ESBL 
producers 
12(63.16) 1(33.33) 1(33.33) 20(33.90) 34(40.48) 
MBL 
producer 
5(26.32) 2(66.67) 0(0.00) 15(25.42) 22(26.19) 
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Table 4: Distribution of MBL and ESBL Producers Amongst Community and Clinical Isolates  
Isolates  Number of isolates 
screened 
Number of MBL positive 
isolates (%) 
Number of ESBL-
positive isolates (%) 
Community 59 15 (25.42) 20 (33.90) 
Clinical 25 7 (28.00) 14 (56.00) 
Total 84 22(26.19) 34(40.48) 
 
Table 5: Occurrence of ESBL producers among MBL-producing isolates 
Isolates No of MBL-producing isolates 
No of MBL isolates producing 
ESBLs (%) 
E. coli 18 3 (16.67) 
Pseudomonas aeruginosa 1 1 (100.00) 
Klebsiella pneumoniae 3 3 (100.00) 
TOTAL 22 7 (31.82) 
 
The overall ESBLs prevalence was 40.48%, with 
clinical isolates producing more ESBLs (56.00%) 
than isolates obtained from the community 
(33.90%) Results are shown in Table 4. Among 
the isolates found to produce MBLs, 7 (28.00%) 
isolates also produced ESBLs. Co-production of 
ESBL was observed in 100% of MBL-
positive Klebsiella 
pnuemoniae and Pseudomonas 
aeruginosa (Table 5). 
 
DISCUSSION 
The ability to produce beta-lactamase enzymes is 
the major cause of bacterial resistance to beta-
lactam antibiotics. The results of our study 
indicate ESBLs and MBLs were prevalent in both 
clinical and community isolates. The observed 
prevalence of 25% and 33% in MBLs and ESBLs 
respectively among healthy children is a call for 
the need to strengthen the fields of sanitation 
amongst children in primary schools in Delta 
State. The emergence and dissemination of these 
beta-lactamase enzymes thus decreased the 
usefulness of beta-lactam drugs in therapy.  
Reports on MBLs and ESBLs production have 
been documented in clinical settings by different 
authors (Toleman et al., 2005; Marchiaro et al., 
2005; Manoharan et al., 2010; Kaleem et al., 
2010; Enwuru et al., 2011; Egbebi and 
Famurewa, 2011; Yusuf et al., 2012). 
 
Reports on community-onset are gradually on the 
increase (Walsh et al., 2005; Pitout and 
Laupland, 2008). Community children with no 
history of travel to endemic countries or recent 
history of hospitalization have been found to 
harbor isolates carrying ESBL and MBL genes 
(Logan and Bonomo, 2016). The cause of 
community-acquired infections is not yet clear, 
however cross contamination due to poor hand 
washing practice amongst school children is a 
possible route, allowing the transmission of 
bacteria to and among the children via physical 
contact and during consumption of food. Beta 
lactamases are usually encoded on plasmids and 
as such can be easily transmitted between 
different bacterial species by horizontal gene 
transfer. Asymptomatic children may therefore be 
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healthy carriers of MBL or ESBL-producing 
Enterobacteriaceae (Viau et al., 2012; Yaffee et 
al., 2015).  
 
A high prevalence of 25% among community 
isolates is worrying. Treatment of severe clinical 
and community acquired infections rely on 
carbapenems (Wong-Beringer, 2001; Falagas 
and Karageorgopoulos, 2009; Paterson, 2010). 
They are thus considered the first choice for 
treatment of patients infected with MBL or ESBL-
producing Enterobacteriaceae. Isolates producing 
MBL were resistant to the carbapenem; 
meropenem as indicated by carpabenamase 
production tests. The situation could complicate 
therapy if and when the community children 
become ill. 
 
Klebsiella pneumoniae (75.00%) was the most 
prevalent ESBL producer in this study (Table 
2). Klebsiella spp. are opportunistic pathogens 
and primarily attack immuno-compromised 
individuals who are hospitalized. Egbebi and 
Famurewa (2011) conducted a study on the 
prevalence of ESBLs in Klebsiella spp. across 
several States in Nigeria and reported high 
prevalence rates of between 43.6% - 72.5% in 
Lagos, Ondo, Ekiti and Osun States. Several 
authors have also found Klebsiella spp. to be 
ESBL producers in their studies (Livrelli et al., 
1996; Lal et al., 2007). Resistance 
of Klebsiella spp. may be due to the presence of 
capsule that gives protection to the cells and 
presence of multidrug resistance efflux pump. 
They also spread easily and are efficient at 
acquiring and disseminating resistance plasmid 
(Chaudhary and Aggarwal, 2004; Gruteke, 2003; 
Yusha’u, 2010). 
 
One important finding in this study is that of the 
22 isolates positive for MBL production, 7 
(31.82%) also co-produced ESBLs with 100% of 
the Pseudomonas aeruginosa and Klebsiella spp. 
expressing co-production (Table 5). This may 
mean an increase in horizontal transfer of 
resistance trait, commonly observed amongst 
plasmid carrying  MBL or ESBL-producing 
pathogens which often demonstrate additional 
mechanisms that give rise to co-resistance to 
many other antibiotics (Paterson, 2004), depleting 
the choice of therapy.  
 
CONCLUSION 
The findings in this study have demonstrated the 
presence of MBL- and ESBL-producing bacteria 
strains from community and hospital subjects 
within Delta State, Nigeria. It also highlights an 
emerging problem;that healthy individuals may be 
reservoirs of resistant bacteria in the community, 
emphasizing the importance of surveillance. 
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